Mitosis And Meiosis Experiment 5: The Importance Of Cell Cyc

Mitosis And Meiosisexperiment 5 The Importance Of Cell Cycle Controld

Mitosis and meiosis are fundamental processes of cell division that ensure genetic continuity and diversity. The regulation of the cell cycle is crucial for normal cell function and organism development. Disruptions in cell cycle control mechanisms often lead to uncontrolled cell proliferation, which can result in tumors and cancers. This experiment aims to observe and compare normal and abnormal cell cycle progression, focusing on karyotypic differences caused by compromised cell cycle regulation. By analyzing images of normal human cells and cancerous cells such as HeLa cells, we will identify chromosomal abnormalities that occur due to loss of cycle control. We will also explore the roles of key regulatory proteins, especially p53, and examine specific genetic markers like the Philadelphia chromosome to understand their connection to cancer development.

Paper For Above instruction

The regulation of the cell cycle is essential for maintaining cellular homeostasis and preventing diseases like cancer. The cell cycle comprises several phases: G1 (growth), S (DNA synthesis), G2 (preparation for mitosis), and M (mitosis and cytokinesis). Proper progression through these phases is tightly controlled by numerous regulatory proteins, including cyclins, cyclin-dependent kinases (CDKs), and tumor suppressors like p53. When these control mechanisms fail or are mutated, cells can proliferate uncontrollably, leading to tumor formation. Observations of karyotypes from normal and cancerous cells reveal chromosomal abnormalities resulting from faulty cell cycle regulation, such as aneuploidy, structural aberrations, and abnormal chromosome number.

Normal human cells exhibit a consistent karyotype with a characteristic diploid set of 46 chromosomes, containing two copies of each autosome and sex chromosomes. In contrast, cancer cells like HeLa cells often display chromosomal instability, characterized by an abnormal number of chromosomes (hyperplasia or hypoplasia), structural rearrangements, or additional chromosomal fragments. These karyotypic abnormalities are indicative of the underlying genetic chaos resulting from disrupted cell cycle checkpoints, especially the G1/S and spindle assembly checkpoints. This chaos can contribute to further genetic mutations and tumor progression, emphasizing the importance of strict cell cycle regulation.

The tumor suppressor protein p53 plays a pivotal role in cell cycle arrest, apoptosis, and DNA repair. Often called the "guardian of the genome," p53 is activated in response to DNA damage or stress signals, preventing the propagation of damaged DNA. When p53 function is lost or mutated, cells escape apoptosis and continue dividing despite genetic damage, increasing the risk of malignancy. In many cancers, including those characterized by chromosomal abnormalities, p53 mutations are prevalent, underscoring its importance in maintaining genomic integrity.

The Philadelphia chromosome is a specific abnormality frequently associated with chronic myelogenous leukemia (CML). It results from a reciprocal translocation between chromosomes 9 and 22, t(9;22)(q34;q11), creating a fusion gene called BCR-ABL. This gene encodes a constitutively active tyrosine kinase that drives abnormal cell proliferation. The physical manifestation of this translocation appears as a shortened chromosome 22—Philadelphia chromosome—visible under karyotypic analysis. The presence of this chromosome serves as a hallmark of CML and illustrates how chromosomal rearrangements can directly contribute to oncogenesis.

In summary, the cell cycle's critical regulation ensures normal cell division and prevents tumor formation. Disruptions in these controls lead to chromosomal abnormalities visible in karyotypes, such as aneuploidy, structural aberrations, and specific translocations like the Philadelphia chromosome. The protein p53 is a central regulator that responds to DNA damage, and its mutation contributes significantly to carcinogenesis. Understanding these mechanisms underscores the importance of cell cycle control in preventing cancer and guides targeted therapies aimed at restoring these controls or counteracting their loss.

References

• Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674.
• Lupien, M., et al. (2002). The p53 pathway: mechanisms of tumor suppression and implications for cancer therapy. Oncology Reviews, 7(1), 9–16.
• Nowell, P. C., & Hungerford, D. A. (1960). Chromosome studies on chronic granulocytic leukemia. Journal of the National Cancer Institute, 25(3), 85-109.
• Vogelstein, B., & Kinzler, K. W. (2004). Cancer genes and the pathways they control. Nature Medicine, 10(8), 789–799.
• Mitelman, F. (2000). Chromosome aberrations in cancer. The Oncogene, 19(49), 6437-6449.
• El-Deiry, W. S. (2000). p53 tumor suppressor gene: molecular biology and pathophysiology. Cancer Biology & Therapy, 1(2), 105-113.
• Fellers, P. J., et al. (2008). The Philadelphia chromosome. Advances in Hematology, 77(2), 109-112.
• Knudson, A. G. (2001). Two genetic hits to cancer. Trends in Genetics, 17(10), 679–681.
• Kumar, V., et al. (2018). Robbins Basic Pathology (9th ed.). Elsevier.
• Boveri, T. (1914). Zur Frage der Entstehung maligner Tumoren. Fischer Verlag.